# reload+after+2024-01-22 19:46:23.911413
address1§Bahnhofstrasse 7
city§Zug
zip§6300
country§Switzerland
phone§41 58 810 0182
website§https://oculis.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.
fullTimeEmployees§28
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Riad  Sherif M.B.A., M.D.', 'age': 55, 'title': 'CEO & Director', 'yearBorn': 1968, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sylvia  Cheung', 'age': 48, 'title': 'Chief Financial Officer', 'yearBorn': 1975, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Weibo  Ding', 'age': 52, 'title': 'Global COO & GM of China', 'yearBorn': 1971, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Bastian  Dehmel', 'age': 52, 'title': 'Chief Development Officer & Head of Development', 'yearBorn': 1971, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Joanne  Chang M.D., Ph.D.', 'age': 62, 'title': 'Head of Medical Affairs & Chief Medical Officer', 'yearBorn': 1961, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Páll Ragnar Jóhannesson', 'age': 42, 'title': 'Chief Strategy Officer', 'yearBorn': 1981, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Fang  Li', 'title': 'Senior Vice President of Regulatory Affairs', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Rebecca  Weil', 'title': 'Chief Commercial Officer', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.217
priceToSalesTrailing12Months§450.24887
currency§USD
dateShortInterest§1702598400
forwardEps§-1.7
exchange§NGM
quoteType§EQUITY
shortName§Oculis Holding AG
longName§Oculis Holding AG
firstTradeDateEpochUtc§1621344600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§48d18c2f-9253-3694-a9c9-9afae38b7b9c
gmtOffSetMilliseconds§-18000000
targetHighPrice§63.97
targetLowPrice§20.99
targetMeanPrice§32.1
targetMedianPrice§28.98
recommendationMean§1.3
recommendationKey§strong_buy
numberOfAnalystOpinions§8
quickRatio§4.911
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
